Chemical firm Epigral Ltd on Monday reported 38 per cent decline in consolidated net profit at ₹99.74 crore for the quarter ended June and said it will invest ₹600 crore to set up new plants in Gujarat.Its net profit stood at ₹160.79 crore in the year-ago period.Total income, however, rose to ₹709.46 crore during the first quarter of this fiscal from ₹614.79 crore in the year-ago period, according to a regulatory filing.On the falling profit, the company explained that in April-June 2025-26, it shifted to new tax rate of 25.17 per cent. As a result, the deferred tax liability reduced by Rs 81 crore and the profit after tax stood at ₹160 crore.Epigral Ltd said it board approved entry into the Epoxy Resin and Formulations business with a planned production capacity of 1.25 lakh tonne per annum and also setting up Multi-Purpose Plant (MPP)."The company will undertake the project with an estimated capex investment of approximately ₹600 crore. The company expects to commission the commercial plant in H2FY28," the filing said.Epigral said the expansion marks its forward integration into the advanced materials and specialty chemicals segment.Epoxy Resin is a critical material used in high-performance and quality-driven applications such as windmill blades, fiber reinforced polymers, tile adhesives, industrial coatings, chemical storage systems, electrical insulation, marine structures, and automotive components.Epigral is also setting up a Multi-Purpose Plant (MPP) to manufacture downstream products of the Epichlorohydrin and Chlorotoluenes value chains. The facility is aimed at addressing the growing domestic demand for pharmaceutical and agrochemical intermediates and water treatment chemicals in India.Established in 2007, Epigral Limited is an integrated chemical manufacturer. It operates a manufacturing complex at Dahej, Gujarat.The company's portfolio includes key products such as caustic soda, caustic potash, chloromethanes, hydrogen peroxide, CPVC, epichlorohydrin, and chlorotoluenes value chain.Published on July 27, 2026